Document:

EXECUTION VERSION

 

DISTRIBUTION, LICENSE AND MANUFACTURING
AGREEMENT

FOR GLAMSMILE VENEER PRODUCTS

 

by and among 

 

REMEDENT, INC.

 

REMEDENT N.V.

 

and

 

GLAMSMILE DENTAL TECHNOLOGY, LTD.

 

Dated as of 

 

January 20, 2012

 

    	 

    	 

    

 

Table
of Contents

 

	 	 	Page
	 	 	 
	1.	Defined Terms.	1
	 	 	 
	2.	Distribution Rights.	1
	 	 	 
	3.	Intellectual Property License Rights.	2
	 	 	 
	4.	Enforcement of Rights.	5
	 	 	 
	5.	Sales Assistance and Regulatory Matters.	5
	 	 	 
	6.	Term and Termination.	6
	 	 	 
	7.	Representations and Warranties.	6
	 	 	 
	8.	Confidentiality.	8
	 	 	 
	9.	Indemnification.	9
	 	 	 
	10.	Miscellaneous.	11

 

    	i

    	 

    

 

DISTRIBUTION, LICENSE AND MANUFACTURING
AGREEMENT

 

THIS DISTRIBUTION,
LICENSE AND MANUFACTURING AGREEMENT (this “Agreement”) dated as of January 20, 2012, (the “Effective
Date”) by and among Remedent, Inc, a Nevada corporation (“Remedent Nevada”), Remedent N.V., a company incorporated
under the laws of Belgium (“Remedent Belgium) ( collectively “Remedent”) and GlamSmile Dental Technology, Ltd.,
a company incorporated under the laws of the Cayman Islands (“GlamSmile”). Remedent and GlamSmile may also be referred
to as a “Party” and collectively as the “Parties.”

 

WHEREAS, Remedent
possesses certain Intellectual Property Rights applicable to the manufacturing, marketing, distributing, licensing and selling
its veneer products in the “B2C Market” (as defined therein);

 

WHEREAS, Remedent
Belgium had previously entered into that certain Intellectual Property Sale Agreement, dated July 29, 2011, (the “Prior Agreement”)
with GlamSmile , Ltd., a company organized under the laws of Hong Kong (“GlamSmile HK”) and at the time a controlled
subsidiary of Remedent Nevada;

 

WHEREAS, in
connection with a venture financing of GlamSmile HK’s business, Remedent and GlamSmile HK desire to reorganize their business
into a Cayman Island holding company by forming GlamSmile for such purposes, and to re-align the ownership of the Intellectual
Property covered under the Prior Agreement by entering into this Agreement and by amending and restating the Prior Agreement as
a Sub-Distribution, License and Manufacturing Agreement under this Agreement; and

 

WHEREAS, in
furtherance of the foregoing recitals, Remedent now desires to appoint GlamSmile as the exclusive distributor and licensee of GlamSmile
Veneer Products bearing the “Glamsmile” name and mark in the Territory (as defined herein) with rights to manufacture
the GlamSmile Veneer Products for in the Territory and GlamSmile desires to accept such appointment, all upon the terms and conditions
set forth in this Agreement;

 

NOW, THEREFORE,
in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Remedent and GlamSmile hereby agree as follows.

 

1.           Defined
Terms.

 

Capitalized terms used
herein without definition shall have the respective meanings given to them in Schedule 1.

 

2.           Distribution
Rights.

 

2.1         Appointment
as Distributor of the GlamsSmile Veneer Products.

 

    	1

    	 

    

 

2.1.1    Exclusive
Distributor. Subject to the terms and conditions in this Agreement, Remedent hereby appoints GlamSmile as the exclusive distributor
(exclusive even as to Remedent) to market, distribute, license and sell GlamSmile Veneer Products bearing the “GlamSmile”
name and mark in the Territory, and GlamSmile hereby accepts this appointment. For each market in the Territory, GlamSmile may
appoint one or more sub-distributors and subcontractors to market, distribute, license and sell the GlamSmile Veneer Products bearing
the “GlamSmile” name and mark in the Territory.

 

2.1.2    Sub-distributors.
GlamSmile may authorize sub-distributors and subcontractors to market, distribute, license and sell GlamSmile Veneer Products in
the Territory. GlamSmile shall not sell or otherwise transfer GlamSmile Veneer Products to any sub-distributor or subcontractor
until such sub-distributor or subcontractor enters into a form of written agreement ("Sub-distributor Agreement")
with GlamSmile , which shall include provisions to bind such sub-distributor or subcontractor to terms and conditions substantially
similar to the product and territorial scope and other limitations set forth in this Agreement with a notice to Remedent.

 

2.1.3    Remedent-Hidens
Agreement. Remedent shall use its commercially reasonable efforts to either terminate or assign the Remdent-Hidens Agreement
to GlamSmile as soon as practical after the Effective Date.

 

 

3.           Intellectual
Property License Rights.

 

3.1         Grants.
In consideration of the issuance of two million eight hundred fifty seven thousand one hundred forty three (2,857,143) shares of
GlamSmile ’s Preference A-1 Shares and in further consideration of the sum of Two Hundred Fifty Thousand United States Dollars,
receipt of which is hereby acknowledged as an off set to payment of certain invoices of GlamSmile Asia, Ltd., in a like amount,
Remedent grants the following licenses to GlamSmile :

 

3.1.1    Use
of Existing Intellectual Property in the Territory. Subject to the terms and conditions in this Agreement and the Den-Mat Agreement,
Remedent hereby grants to GlamSmile a perpetual, irrevocable, exclusive (except as to Den-Mat), royalty free, sublicensible, transferable
right and license to use, make, develop, produce, manufacture, modify, market, sell, distribute,
practice, commercialize, exploit, or import within the Territory the Intellectual Property owned or used by Remedent that
is embedded in the GlamSmile Veneer Products as it exists on the Effective Date and the exclusive right to use the trademark “GlamSmile”
(exclusive even as to Den-Mat and Remedent) within the Territory subject to the terms under Sections 3.5 and 3.6. Notwithstanding
the foregoing, (a) Remedent retains the right to use and license to any Person performing contract manufacturing for Remedent such
Intellectual Property solely in connection with the manufacture of the GlamSmile Veneer Products and for internal product development
related to the GlamSmile Veneer Products, (b) this grant shall not include any rights to the name or trademark ‘Remedent’,
and (c) GlamSmile and Remedent agree that GlamSmile ’s right and license to use the Intellectual Property within the Territory
shall be non-exclusive to Den-Mat’s pre-existing rights under the Den-Mat Agreement subject to Section 3.7 herein, except
for the right to use the trademark “GlamSmile” which shall be exclusive. For purposes of clarity, GlamSmile shall not
use the name or trademark ‘Remedent’ without the prior written consent of Remedent, and GlamSmile shall not use the
name or trademark ‘GlamSmile’ outside the Territory without the prior written consent of Remedent. Notwithstanding
anything to the contrary in this Agreement, neither GlamSmile nor any sub-distributor nor any Affiliate, permitted successor or
assignee of any of the foregoing, shall, directly or indirectly, make any reference or comparison in its marketing materials or
in any advertising or sales efforts to any Den-Mat product or trademark including, but not limited to, LumiSmile, Lumineers, Luminate,
or Lumitray, without the prior written consent of Remedent.

 

    	2

    	 

    

 

3.1.2    Use
of Future Intellectual Property. Subject to the terms and conditions in this Agreement and the Den-Mat Agreement, Remedent
hereby grants to GlamSmile a perpetual, irrevocable, exclusive (except as to Den-Mat), royalty free, sublicensible, transferable
right and license to use make, develop, produce, manufacture, modify, market, sell, distribute, practice,
commercialize, exploit, or import within the Territory the Intellectual Property owned or used by Remedent that is related
to the GlamSmile Veneer Products and is developed (whether directly or indirectly, individually or jointly with others) by Remedent
(or any of Remedent’s Affiliates) or acquired by Remedent (or any of Remedent’s Affiliates) after the Effective Date,
except that (a) such grant is subject to the limitations set forth in Section 3.4, (b) Remedent retains the right to use
and license to any Person providing contract manufacturing to Remedent (concurrently with GlamSmile’s right to use) such
Intellectual Property solely in connection with the manufacture of the GlamSmile Veneer Products and for internal product development
related to the GlamSmile Veneer Products and (c) Remedent retains the right to use and license to any Person providing contract
manufacturing to Remedent (concurrently with GlamSmile’s right to use) any of such Intellectual Property directly related
to the GlamSmile Veneer Product manufacturing process solely in connection with the manufacture of the GlamSmile Veneer Products.

 

3.2         Manufacturing
Rights. Subject to Section 3.1.1, Remedent hereby grants to GlamSmile the perpetual, irrevocable, royalty free exclusive right
and license to manufacture and produce the GlamSmile Veneer Products bearing the “GlamSmile” name and mark for its
sales within the Territory. GlamSmile may grant one or more sublicenses to any of its Affiliates within the Territory for purposes
of manufacturing and producing the GlamSmile Veneer Products of its sales within the Territory.

 

3.3         Ownership
of Intellectual Property.

 

3.3.1    Independently
Developed Intellectual Property. Each Party shall have the sole and exclusive right to apply for, prosecute and obtain all
rights, grants, registrations, orders or proprietary interests of any nature, including, without limitation, patents, copyrights,
industrial design and trademark and service mark registrations and any other registrations or grants of rights that are analogous
thereto in any and all countries throughout the world in respect of Intellectual Property now owned or independently developed
by such Party after the Effective Date. In addition, with respect to any Intellectual Property related to the GlamSmile Veneer
Products developed by Remedent, Remedent, in its sole discretion at its own cost and expense may apply for, prosecute and obtain
all rights, grants, registrations, orders or proprietary interests of any nature, including, without limitation, patents, copyrights,
industrial design and trademark and service mark registrations and any other registrations or grants of rights that are analogous
thereto in any and all countries throughout the world.

 

    	3

    	 

    

 

3.3.2    Jointly
Arising Intellectual Property. In the event the Parties jointly develop any Intellectual Property related to the GlamSmile
Veneer Products for which a patent or copyright would be available, and if either Remedent or GlamSmile desires to pursue a patent
or copyright on such Intellectual Property in any jurisdiction, then the Party who desires to pursue such patent or copyright (in
this capacity, the “Filing Party”), shall deliver a notice (a “Notice of Intent to File”) to the other
Party identifying the subject Intellectual Property, whether the filing will be for a patent or copyright and the jurisdiction
in which such filing will be made. The Party receiving such Notice of Intent to File may then elect to participate in such filing,
in which case it shall cooperate with the Filing Party in connection with such filing and the subsequent prosecution thereof and
share the related costs and expenses evenly with the Filing Party. If the Party receiving such Notice of Intent to File does not
deliver to the Filing Party a notice that it elects to participate in such filing and prosecution within thirty (30) days after
receiving such Notice of Intent to File, the Filing Party may proceed with such filing and prosecution individually. If a Filing
Party proceeds with such a filing and prosecution individually: (a) the other Party hereby authorizes the Filing Party to identify
such Party as a co-owner of the subject Intellectual Property and a co-holder of the rights filed for, (b) the other Party shall
provide such assistance as the Filing Party may reasonably request in connection therewith, (c) the Filing Party shall be reimbursed
for the costs and expenses incurred by it in connection with such filing and prosecution as a priority payment from any sale, license
fees, royalties, proceeds of infringement actions or other amounts received by Remedent or GlamSmile with respect to such Intellectual
Property in the territory covered by such patent or copyright before the remaining is shared evenly between the Parties, (d) the
Filing Party shall be reimbursed for the costs and expenses incurred by it in connection with providing cooperation as a second
priority payment from any sale, license fees, royalties, proceeds of infringement actions or other amounts received by Remedent
or GlamSmile with respect to such Intellectual Property in the territory covered by such patent or copyright before the remaining
is shared evenly between parties, (e) each of GlamSmile and Remedent shall take such actions as the other may reasonably request
to implement the provisions of this Section 3.3.2 with respect to such Intellectual Property and (f) the patents or copyrights
so obtained shall be jointly owned by Remedent and GlamSmile.

 

3.4         Rights
in Future Intellectual Property. Remedent shall promptly notify GlamSmile of any Intellectual Property developed (whether directly
or indirectly, individually or jointly with others) by Remedent (or any of Remedent’s Affiliates) or acquired by Remedent
(or any of Remedent’s Affiliates) after the Effective Date related to the GlamSmile Veneer Products and concurrently therewith
deliver such Intellectual Property to GlamSmile. The grants provided in Section 3.1 shall not apply to any Intellectual Property
licensed by Remedent after the Effective Date for which, despite commercially reasonable efforts, Remedent is not able to obtain
a sublicense or the right to grant a sublicense enabling Remedent to grant the license contemplated by Section 3.1. Upon being
advised that any Intellectual Property Remedent desires to license from another Person after the Effective Date would not be available
to GlamSmile as contemplated by Section 3.1, Remedent shall give prompt written notice of such event to GlamSmile and thereafter
will not license such Intellectual Property without first cooperating with GlamSmile for a period of at least fifteen (15) Business
Days, in such manner as GlamSmile may reasonably request, to obtain a license of such Intellectual Property, on commercially reasonable
terms, in the scope contemplated by Section 3.1 or in such more limited scope as GlamSmile may agree.

 

    	4

    	 

    

 

3.5         Transfer
of Ownership of the Trademark “GlamSmile” in the Republic of China (Taiwan). Subject to the terms and conditions
of this Agreement, as of the Effective Date, Remedent shall, or cause its Affiliates to, irrevocably transfer to GlamSmile or its
designated Affiliate all of the right, title and interest of Remedent and its Affiliates in and to the trademark “GlamSmile”
in the Republic of China (Taiwan). Remedent shall, or cause its Affiliates to, complete the transfer of the trademark “GlamSmile”
in the Republic of China (Taiwan) within ninety (90) days of the Effective Date by perfecting changes of titles and registrations
of the trademark “GlamSmile” in the Republic of China (Taiwan).

 

3.6         Confirmation
or Transfer of Ownership of the Trademark “GlamSmile” in the People’s Republic of China. Remedent agrees and
confirms that GlamSmile is the sole owner having all the rights, title and interest of the trademark “GlamSmile” in
the People’s Republic of China, or otherwise shall, or cause its Affiliates to, irrevocably transfer to GlamSmile or its
designated Affiliate all of the right, title and interest of Remedent and its Affiliates in and to the trademark “GlamSmile”
in the People’s Republic of China and complete the transfer of the trademark “GlamSmile” in the People’s
Republic of China within sixty (60) days of the Effective Date by perfecting changes of titles and registrations of the trademark
“GlamSmile” in the People’s Republic of China.

 

3.7         Expansion
of Intellectual Property Rights in the Territory. Remedent agrees to use its best efforts to amend the Den-Mat Agreement within
one hundred fifty (150) days of the Effective Date to provide that Remedent shall retain lien-free interests or have exclusive
rights to use the GlamSmile Veneer Technology in the Territory, even as to Den-Mat , whether it be in the B2C Market or otherwise.
If Remedent is successful in amending the Den-Mat Agreement expanding the Intellectual Property rights in the Territory, Remedent
shall promptly amend this Agreement to assign or transfer all expanded rights it may have regarding GlamSmile Veneer Technology
in Territory to GlamSmile, execute any documents required by the applicable laws or reasonably requested by GlamSmile, and make
any other necessary assistance to effect and perfect such assignment or transfer, provide further, if the expanded rights in Territory
are not assignable, or otherwise transferable, to GlamsSmile by operation of law, then Remedent hereby grants to Glamsmile a fully
paid-up, irrevocable, perpetual, exclusive, license to use make, develop, produce, manufacture, modify,
market, sell, distribute, practice, commercialize, exploit, or import within the Territory the Intellectual Property owned
or used by Remedent that is embedded in the GlamSmile Veneer Products as it exists on the Effective Date. If Remedent fails to
amend the Den-Mat agreement under section 3.7 herein, Remedent shall transfer a total of 500,000 ordinary shares of GalmSmile owned
by Remedent to the Purchasers (as defined in the Share Purchase Agreement entered into by the Parties) at no cost to Purchasers.

 

4.           Enforcement
of Rights. 

 

4.1         Intellectual
Property.

 

4.1.1    From
and after the date of this Agreement, Remedent, have the right to maintain all of its Intellectual Property related to the GlamSmile
Veneer Products and have the first option to enforce all of its rights to protect against any infringing or unauthorized use of
such Intellectual Property by any Person in Territory at Remedent’s own cost, provided however, if Remedent decides not to
take actions against infringement, GlamSmile shall have the right to commence actions for infringement and enforce its rights granted
herein in the Territory and settle any such actions, and Remedent hereby agrees to assist and cooperate with GlamsSmile to the
extent necessary in such actions.

 

    	5

    	 

    

 

5.         Sales
Assistance and Regulatory Matters. 

 

5.1         Sales
Assistance. If Remedent is contacted by any Person seeking to acquire GlamSmile Veneer Products in the Territory and within
the B2C Market or GlamSmile Veneer Products bearing the “Glamsmile” name and mark in the Territory, Remedent shall
refer such sales lead promptly to GlamSmile.

 

5.2         Regulatory
Matters. GlamSmile shall be responsible for obtaining all regulatory approvals required for it to act as a distributor of the
GlamSmile Veneer Products in Territory where the nature of its activities requires such approval to be obtained. GlamSmile shall
provide to Remedent, upon reasonable request, materials in its possession and access to its employees, in each case that the Remedent
reasonably determines to be relevant to any regulatory approval sought or required to be obtained by it with respect to the distribution,
marketing or sale of the GlamSmile Veneer Products outside the Territory, and agrees to cover GlamSmile’s cost for activities
in response to Remedent’s request.

 

6.         Term
and Termination.

 

6.1         Term.
This Agreement shall remain in effect perpetually unless and until terminated as set forth in this Section 6.

 

6.2         Termination
for Cause.

 

6.2.1    By
Remedent. This Agreement may be terminated by Remedent: (a) at any time upon sixty (60) days’ prior written notice to
GlamSmile in the event GlamSmile materially breaches any of its obligations under this Agreement and fails to cure such breach
within such sixty (60) day period; or (b) immediately upon notice of termination to GlamSmile if an involuntary or voluntary proceeding
shall have been instituted in a court having jurisdiction seeking a decree or order for relief in respect of GlamSmile under any
applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or for the appointment of a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official) of GlamSmile, or for any substantial part of its property, or
for the winding-up or liquidation of its affairs, or GlamSmile fails generally to pay its debts as they become due, or takes any
corporate action in furtherance of any of the foregoing.

 

6.2.2    By
GlamSmile. This Agreement may be terminated by GlamSmile: (a) at any time upon sixty (60) days’ prior written notice
to Remedent in the event of Remedent materially breaches any of its obligations, including, but not limited to, its representations
and warranties, under this Agreement and fails to cure such breach within such sixty (60) day period.

 

6.3         Survival.
The provisions of Sections 1, 2.1, 3.1, 3.5, 3.6, 3.7, 6.3, 8, and 9 shall survive any termination
of this Agreement, and termination of this Agreement shall not release any Party from liability to the other Parties for any breach
of this Agreement occurring or arising prior to such termination.

 

    	6

    	 

    

 

7.         Representations
and Warranties.

 

7.1         Representations
and Warranties of Remedent. As of the Effective Date, Remedent, Inc., and Remedent N.V. represent and warrant to GlamSmile
as follows:

 

7.1.1    Organization.
Remedent N.V. is a duly organized company, validly existing and in good standing under the laws of Belgium and has the corporate
power and authority to conduct its business as it is currently conducted by it and to own, operate and lease its assets. Remedent,
Inc. and Remedent N.V. are duly licensed or qualified to do business as a foreign corporation and is in good standing in each jurisdiction
in which they are required to be so licensed or qualified, except where the failure to be so qualified would not have a material
adverse effect on their business or their ability to fulfill its obligations under this Agreement.

 

7.1.2    Authorization.
Remedent, Inc. and Remedent N.V. have all required power and authority to enter into this Agreement and the other agreements, documents
and instruments contemplated by this Agreement to which it will be a party (collectively, the “Remedent Transaction Documents”),
to perform their obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby, including
the appointments and grants set forth in this Agreement. The execution and delivery of this Agreement and the other Remedent Transaction
Documents to which they are a party and the consummation of the transactions contemplated hereby and thereby have been duly authorized
by directors and, to the extent required by applicable law or otherwise, by stockholders entitled to vote thereon, and no other
corporate action or approval by them are necessary for the execution, delivery or performance of this Agreement or such other Remedent
Transaction Documents. This Agreement has been, and each of the other Remedent Transaction Documents to which Remedent, Inc. and
Remedent N.V. are parties will be when executed and delivered in accordance with the terms and conditions hereof, duly executed
and delivered by them, and this Agreement is, and each of the other Remedent Transaction Documents to which they are a party will
be when executed and delivered in accordance with the terms and conditions hereof, a valid and binding obligation of Remedent,
Inc. and Remedent N.V. respectively, enforceable against them in accordance with each of its terms, except as such enforceability
may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereafter in effect, relating
to or limiting creditors’ rights generally and (ii) general principles of equity (whether considered in an action in equity
or at law).

 

    	7

    	 

    

 

7.1.3    Remedent
Intellectual Property. Schedule 7.1.3 lists each patent, registered trademark, design mark, service mark and trade name,
registered copyright and domain name, and each application for any of the foregoing, that is included among the Intellectual Property
owned by or licensed to Remedent embedded in GlamSmile Veneer Products. Except as set forth in Schedule 7.1.3, (a) Remedent
has all right, title and interest in and to the Intellectual Property related to the GlamSmile Veneer Products owned by it, free
and clear of all liens or other encumbrances; (b) there is no claim or notice of infringement of the Intellectual Property rights
of any other Person pending or threatened in writing within the two (2) year period preceding the date hereof, against Remedent
relating to the operation of Remedent’s business; (c) each material item of Intellectual Property related to the GlamSmile
Products owned by Remedent is valid, subsisting, in full force and effect, has not been abandoned or passed into public domain,
and all necessary registration, maintenance and renewal documentation and fees in connection with such Intellectual Property of
Remedent have been timely filed with the appropriate authorities and paid; (d) to the Knowledge of Remedent, each material item
of Intellectual Property related to the GlamSmile Veneer Products licensed to and used by Remedent is valid, subsisting, in full
force and effect, has not been abandoned or passed into public domain, and all necessary registration, maintenance and renewal
documentation and fees in connection with such Intellectual Property used by Remedent have been timely filed with appropriate authorities
and paid; (e) to the Knowledge of Remedent, no Person is infringing or misappropriating the Intellectual Property of Remedent except
for such infringements or misappropriations that would not reasonably be likely to have, individually or in the aggregate, a material
adverse effect on Remedent, its business or its ability to fulfill its obligations under this Agreement; (f) no present or former
employee of Remedent has any proprietary, financial or other interest, direct or indirect, in any material item of the Intellectual
Property of Remedent; (g) Remedent has taken reasonable precautions to protect trade secrets constituting material Intellectual
Property owned or used by Remedent, including the execution of appropriate agreements, (h) to the
Knowledge of Remedent, Remedent has not entered into any agreements, commitments or other arrangement with any other Third Party,
in each case that would (1) prohibit Remedent from fulfilling its obligations hereunder or (2) be inconsistent or in conflict
with the rights granted to GlamSmile hereunder; and (i) the use by GlamSmile of the Intellectual Property owned or licensed
by Remedent does not infringe, misappropriate or violate any Intellectual Property rights of any Person. 

 

7.2         Representations
and Warranties of GlamSmile. As of the Effective Date, GlamSmile represents and warrants to Remedent as follows:

 

7.2.1    Organization.
GlamSmile is a duly organized company, validly existing and in good standing under the laws of the Cayman Islands, and has the
power and authority to conduct its business as it is currently conducted by it and to own, operate and lease its assets. GlamSmile
is duly licensed or qualified to do business as a foreign limit company and is in good standing (to the extent such concept is
applicable to it) in each jurisdiction in which it is required to be so licensed or qualified, except where the failure to be so
qualified would not have a material adverse effect on GlamSmile, its business or its ability to fulfill its obligations under this
Agreement.

 

    	8

    	 

    

 

7.2.2    Authorization.
GlamSmile has all required power and authority to enter into this Agreement and the other agreements, documents and instruments
contemplated by this Agreement to which it will be a party (collectively, the “GlamSmile Transaction Documents”),
to perform its obligations hereunder and thereunder and to consummate the transactions contemplated hereby and thereby. The execution
and delivery of this Agreement and the other GlamSmile Transaction Documents to which GlamSmile is a party and the consummation
of the transactions contemplated hereby and thereby have been duly authorized by the directors, and to the extent required by law,
the shareholders of GlamSmile entitled to vote thereon, and no other action or approval by GlamSmile is necessary for the execution,
delivery or performance of this Agreement or such other GlamSmile Transaction Documents by GlamSmile. This Agreement has been,
and each of the other GlamSmile Transaction Documents to which GlamSmile is a party will be when executed and delivered in accordance
with the terms and conditions hereof, duly executed and delivered by GlamSmile, and this Agreement is, and each of the other GlamSmile
Transaction Documents to which GlamSmile is a party will be when executed and delivered in accordance with the terms and conditions
hereof, a valid and binding obligation of GlamSmile, enforceable against it accordance with each of its terms, except as such enforceability
may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereafter in effect, relating
to or limiting creditors’ rights generally and (ii) general principles of equity (whether considered in an action in equity
or at law

 

8.         Confidentiality.

 

8.1         Confidential
Information of Remedent. All Confidential Information with respect to Remedent and its Affiliates that is disclosed to GlamSmile
by Remedent, its Affiliates or representatives, whether in physical or intangible form, and all Confidential Information regarding
Remedent of which GlamSmile becomes aware in connection with its performance of under this Agreement, shall be held as confidential
by GlamSmile. Such information shall at all times remain the property of Remedent and Remedent shall own and retain all right,
title and interest therein and thereto. GlamSmile shall hold all Confidential Information in confidence, using the same degree
of care to prevent unauthorized disclosure or access that it uses with its own confidential information of similar type, and shall
not disclose such Confidential Information to others, allow others to access it, or use it in any way, commercially or otherwise,
except in direct furtherance of this Agreement. GlamSmile may disclose Confidential Information to its employees and its attorneys,
accountants and other confidential advisors with a need to know such Confidential Information in connection with this Agreement;
provided, however, that all such employees and advisors are bound by obligations to maintain the confidentiality
of the Confidential Information at least as protective as those set forth in this Agreement. Except as set forth herein, nothing
in this Agreement shall be construed as conveying any other right or license (implied or otherwise) to GlamSmile in such Remedent
Confidential Information.

 

8.1.1    Permitted
Disclosure. If GlamSmile is compelled to disclose all or any part of any Confidential Information by any Governmental Authority,
or if it is required to disclose any Confidential Information in its reports or other filings under applicable law, it shall, to
the extent practicable and subject to applicable laws, first give prompt written notice of such request to Remedent to enable Remedent
to seek a protective order or take other appropriate measures to prevent or modify the disclosure, and shall, at Remedent’s
expense, cooperate in such efforts.

 

8.1.2    Exclusions.
Confidential Information with respect to Remedent and its Affiliates shall not include information if and to the extent GlamSmile
can demonstrate such information: (a) is or becomes known to the public other than by disclosure by GlamSmile in violation of this
Agreement; (b) was known to GlamSmile before disclosure hereunder, without a duty of confidentiality; (c) was independently developed
by GlamSmile outside of this Agreement and without reference to or use of any Confidential Information of Remedent; or (d) was
rightfully obtained by GlamSmile from a third party without a duty of confidentiality in favor of Remedent.

 

    	9

    	 

    

 

8.1.3    Return
of Confidential Information. Upon the termination of this Agreement, GlamSmile shall promptly return to Remedent all Confidential
Information with respect to Remedent and its Affiliates and all copies, summaries, excerpts and abstracts thereof then in its possession.
Notwithstanding the foregoing, GlamSmile may keep one copy of any document requested to be returned or destroyed in the files of
its legal department or outside counsel for record purposes only and for purposes of ensuring compliance with the terms of this
Agreement.

 

8.1.4    Injunctive
Relief. GlamSmile acknowledges and agrees that in the event of any breach or threatened breach of its obligations hereunder
with respect to Confidential Information, damages will not be an adequate remedy and Remedent shall be entitled to obtain injunctive
relief, without having to post a bond or other security.

 

9.         Indemnification.

 

9.1         Indemnification by GlamSmile.
GlamSmile shall defend, indemnify and hold harmless Remedent and its Affiliates and its and their respective officers, directors,
members, managers, employees, agents and representatives from and against any and all claims, judgments, damages, liabilities,
actions, demands, costs, expenses or losses, including reasonable attorneys’ fees and costs (collectively, “Liabilities”),
to the extent resulting from, arising out of, or in connection with, an act or omission of GlamSmile in connection with performance
of its obligations under this Agreement and the other GlamSmile Transaction Documents, or the breach of any representation, warranty
or covenant made by GlamSmile in this Agreement or any of the other GlamSmile Transaction Documents.

 

9.2         Indemnification by Remedent.
Remedent shall defend, indemnify and hold harmless GlamSmile and its Affiliates and its and their respective officers, directors,
members, managers, employees, agents and representatives from and against any and all Liabilities, to the extent resulting from,
arising out of, or in connection with any act or omission by Remedent in connection with performance of its obligations under this
Agreement and the other Remedent Transaction Documents, or the breach of any representation, warranty or covenant made by Remedent
in this Agreement or any of the other Remedent Transaction Documents.

 

9.3         IP
Indemnity. Remedent shall indemnify GlamSmile and its Affiliates and its and their respective officers, directors, members,
managers, employees, agents and representatives from and against any and all Liabilities, to the extent resulting from, arising
out of, or in connection with any infringement or alleged infringement of the GlamSmile Veneer Products, the Intellectual Property
of Remedent, or any use or application thereof upon any Intellectual Property of any Person. If the manufacture, distribution,
marketing, licensing, sale or use of any GlamSmile Veneer Product or Intellectual Property, as contemplated by this Agreement,
is enjoined as a result of any Intellectual Property claim or judgment, then Remedent, in addition to its other obligations under
this Agreement, shall, at its option, (i) obtain for GlamSmile, at Remedent’s expense, any license required for GlamSmile
to manufacture, market, distribute, license and sell the GlamSmile Veneer Products as contemplated by this Agreement, or (ii) redesign
the infringing item or items to be non-infringing, while maintaining the original function thereof or (iii) replace the infringing
item or items with an equivalent, non-infringing item approved by GlamSmile.

 

    	10

    	 

    

 

9.4         Indemnification Procedures.
A Party seeking indemnification under this Section 9 for itself or any of its Affiliates or any of its or their respective
officers, directors, members, managers, employees, agents and representatives (collectively in this capacity, the “Indemnified
Party”) shall promptly notify the Party from whom indemnification is sought (in this capacity, the “Indemnitor”)
of any Liability in respect of which such Indemnified Party intends to claim indemnification; provided, however,
that the failure to so notify the Indemnitor shall not affect the Indemnified Party’s rights to indemnification hereunder
except to the extent that the Indemnitor is materially prejudiced by such failure. With respect to any Liabilities that relate
to a third party claim, the Indemnified Party shall permit the Indemnitor to control the defense of any such Liabilities; provided,
however, if the Indemnified Party reasonably determines that the joint representation of the Indemnified Party and the Indemnitor
by a single counsel would result in a conflict of interest arising out of the joint representation by counsel selected by the Indemnitor
of the interests of the Indemnitor and the Indemnified Party, the Indemnitor shall be entitled to engage separate counsel to represent
the Indemnified Party (at the Indemnitor’s sole cost and expense) and, if the Indemnitor fails to do so, the Indemnitor shall
not be entitled to assume the Indemnified Party’s defense of such Liability. If the Indemnitor assumes the defense of any
Liability, the Indemnitor shall consult with the Indemnified Party for the purpose of allowing the Indemnified Party to participate
in such defense, but in such case the legal expenses of the Indemnified Party incurred as a result of such participation shall
be paid by the Indemnified Party. With respect to any Proceeding for which the Indemnitor has assumed the defense of an Indemnified
Party, the Indemnitor shall promptly inform the applicable Indemnified Party of all material developments related thereto, including
copying such Indemnified Party on all pleadings, filings and other correspondence relating thereto. If the Indemnitor fails to
assume and defend a Liability or if, after commencing or undertaking any such defense, the Indemnitor fails to prosecute such Liability,
the Indemnified Party shall have the right to undertake the defense or settlement thereof. With respect to any Liabilities that
relate to a third party claim, the Indemnified Party shall have the right to settle such Liabilities, provided the Indemnified
Party consents in writing to such settlement, which consent shall not be unreasonably withheld.

 

10.        Miscellaneous.

 

10.1       Expenses.
Except as otherwise specifically provided for in this Agreement, each Party shall bear its expenses, costs and fees (including
attorneys’, auditors’ and financing fees, if any) incurred in connection with the transactions contemplated hereby,
including the preparation, execution and delivery of this Agreement and compliance herewith.

 

10.2       Further
Actions. Subject to the terms and conditions of this Agreement, each Party shall execute and deliver such certificates and
other documents and take such actions as may reasonably be requested by any other Party in order to effect the transactions contemplated
by this Agreement.

 

    	11

    	 

    

 

10.3       Notices.
All notices, requests, demands, waivers and other communications required or permitted to be given under this Agreement shall be
in writing and shall be deemed to have been duly given if: (a) delivered personally; (b) mailed, using certified or registered
mail with postage prepaid; (c) sent by next-day or overnight mail or delivery using an internationally recognized overnight
courier service; (d) transmitted by facsimile machine or electronically by e-mail, as follows:

 

	To Remedent	Remedent, Inc./Remedent N.V
	 	Zunderlaan 1-3 Bus 8,900
	 	Ghent, Belgium
	 	Attn:  Guy De Vreese
	 	Fax:
	 	E-mail:  guyde@remedent.be
	 	 
	with a copy (which shall not	Locke Lord LLP
	constitute notice) sent to:	500 Capitol Mall, Suite 1800
	 	Sacramento, California  95814
	 	Attn:  Scott E. Bartel
	 	Fax:  916-930-2501
	 	E-mail:  sbartel@lockelord.com
	 	 
	To GlamSmile:	GlamSmile Dental Technology, Ltd
	 	 
	 	Attn:  Chief Executive Officer

 

or, in each case, at such other address
as may be specified in writing to the other Parties in accordance with this Section 10.3.

 

All such notices, requests,
demands, waivers and other communications shall be deemed to have been received: (a) if by personal delivery, on the day of
such delivery; (b) if by certified or registered mail, on the third (3rd) Business Day after the mailing thereof;
(c) if by next-day or overnight mail or delivery, on the day delivered, or if by facsimile or e-mail, on the day of a confirmed
transmission.

 

10.4       Binding
Effect; Assignment. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors
and permitted assigns. Remedent shall not assign this Agreement either in whole or in part without the prior written consent of
GlamSmile, provided, however, that Remedent shall have the right to assign this Agreement either in whole or in part
to Affiliates of Remedent, to any successor to all or substantially all of Remedent’s business and in connection with a collateral
assignment to lenders, provided that, in each instance, the assignee shall have acknowledged in writing the existence of this Agreement
and GlamSmile’s rights hereunder. GlamSmile shall not assign this Agreement either in whole or in part without the prior
written consent of Remedent; provided, however, that GlamSmile shall have the right to assign this Agreement either
in whole or in part to Affiliates of GlamSmile, to any successor to all or substantially all of GlamSmile’s business and
in connection with a collateral assignment to lenders. Any attempted assignment or delegation in violation of this Section 10.4
will be void. Except as expressly set forth in Section 8, nothing in this Agreement, expressed or implied, is intended or
shall be construed to confer upon any Person, other than the Parties and the successors and assigns permitted by this Section
10.4, any right, remedy or claim under or by reason of this Agreement.

 

    	12

    	 

    

 

10.5         Amendment;
Waiver. No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless
set forth in writing and duly executed by the Party or Parties against whom enforcement of the amendment, modification, discharge
or waiver is sought. Any such waiver shall constitute a waiver only with respect to the specific matter described in such writing
and shall in no way impair the rights of the Party or Parties granting such waiver in any other respect or at any other time. The
waiver by any of the Parties of a breach of or a default under any of the provisions of this Agreement or a failure to or delay
in exercising any right or privilege hereunder, shall not be construed as a waiver of any other breach or default of a similar
nature, or as a waiver of any of such provisions, rights or privileges hereunder. The rights and remedies herein provided are cumulative
and none is exclusive of any other, or of any rights or remedies that any Party may otherwise have at law or in equity.

 

10.6         Entire
Agreement. This Agreement (including the Exhibits and Schedules referred to herein or delivered hereunder) and the agreements
expressly contemplated to be executed and delivered by the Parties pursuant to this Agreement constitute the entire agreement between
the Parties with respect to the subject matter hereof and supersedes all contemporaneous oral agreements and all prior oral and
written quotations, communications, agreements, understandings of the Parties and written or oral representations of any Party
with respect to the subject matter of this Agreement.

 

10.7         Severability.
If any provision of this Agreement shall be held or declared to be invalid or unenforceable, such invalid or unenforceable provision
shall not affect any other provision of this Agreement, and the remainder of this Agreement, and each Party’s obligations
hereunder, shall continue in full force and effect as though such provision had not been contained in this Agreement and, if permitted
under applicable rules of instruction and interpretation, such provision shall be reformed to the extent necessary to render such
provision valid and enforceable and to reflect the intent of the Parties to the maximum extent possible under applicable law.

 

10.8         Headings.
The headings contained in this Agreement are for reference purposes only and shall not in any way affect the meaning or interpretation
of this Agreement.

 

10.9         Counterparts.
This Agreement may be executed in one or more counterparts, all of which will be considered one and the same agreement and will
become effective when one or more counterparts have been signed by each of the Parties and delivered to the other Parties, regardless
of whether all of the Parties have executed the same counterpart. Counterparts may be delivered via facsimile, electronic mail
(including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes. 

 

    	13

    	 

    

 

10.10       Governing
Law. This Agreement and the rights and obligations of the parties shall be governed by, construed and enforced in accordance
with the laws of the State of California, without giving effect to any choice or conflict of law rule that would cause the application
or the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties.

 

10.11       Consent
to Jurisdiction.

 

10.11.1     Each
of the parties irrevocably and unconditionally submits, for itself and its properties and assets, to the exclusive jurisdiction
of the courts in the State of California, in the County of San Francisco or the United States of America for the Northern District
of California and any appellate court therefrom (collectively, the “California Courts”), in any proceeding arising
out of or relating to this Agreement or the transactions contemplated hereby or for recognition or enforcement of any judgment
relating thereto, and each of the parties irrevocably and unconditionally agrees that all claims in respect of any such proceeding
shall be heard and determined in the California Courts. Each of the parties agrees that a final judgment in any such proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

 

10.11.2    Each
of the parties irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection
which it may now or hereafter have to the laying of venue of any proceeding arising out of or relating to this agreement or the
transactions contemplated hereby in any of the California Courts. Each of the parties irrevocably waives, to the fullest extent
permitted by law, the defense of an inconvenient forum to the maintenance of such proceeding in any of the California Courts.

 

10.12       Waiver
of Punitive and Other Damages and Jury Trial.

 

10.12.1    The
parties to this Agreement expressly waive and forgo any right to recover punitive, exemplary or similar damages in any arbitration,
lawsuit, litigation or proceeding arising out of or resulting from any controversy or claim arising out of or relating to this
agreement or the transactions contemplated hereby.

 

10.12.2    Each
party acknowledges and agrees that any controversy which may arise under this Agreement is likely to involve complicated and difficult
issues, and therefore, to the fullest extent it may legally and effectively do so, it hereby irrevocably and unconditionally waives
any right it may have to a trial by jury in respect of any litigation directly or indirectly arising out of or relating to this
agreement or the transactions contemplated hereby.

 

10.12.3    Each
party certifies and acknowledges that (a) no representative, agent or attorney of any other party has represented, expressly or
otherwise, that such other party would not, in the event of litigation, seek to enforce either of the foregoing waivers, (b) it
understands and has considered the implications of such waivers, (c) it makes such waivers voluntarily, and (d) it has been induced
to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section 10.12.3.

 

    	14

    	 

    

 

10.13         No
Waiver; Remedies. No Party shall by any act (except by written instrument pursuant to Section 10.5), delay, indulgence,
omission or otherwise be deemed to have waived any right or remedy hereunder or to have acquiesced in any default in or breach
of any of the terms and conditions of this Agreement. No failure to exercise, nor any delay in exercising on the part of any Party,
any right, power or privilege hereunder shall operate as a waiver thereof. No single or partial exercise of any right, power or
privilege hereunder shall preclude any other or further exercise thereof or the exercise of any other right, power or privilege.

 

10.14         No
Limitation on Competitive Activities. Nothing in this Agreement shall, or shall be construed to, limit in any way Remedent’s
right and ability to manufacture, market, distribute, license and sell any other product, other than the GlamSmile Veneer Products
or services in the Territory, regardless of whether such other products or services compete with the GlamSmile Veneer Products.

 

10.15         No
Partnership or Joint Venture. Nothing in this Agreement shall be construed as (a) giving any Party any rights as a partner
in or owner of the business of the other Parties, (b) entitling a Party to control in any manner the conduct of the other Parties’
business, or (c) making any Party a joint venturer, joint employer, principal, agent, or employee of the other Parties. Except
as expressly set forth in this Agreement or in any of the agreement or instruments contemplated hereby, no Party shall have, nor
shall it represent itself as having, the power to make any contracts or commitments in the name of or binding upon any of the other
Parties.

 

10.16         Specific
Performance. Each of the Parties acknowledges and agrees that, in the event of any breach of this Agreement, the non-breaching
Party would be irreparably and immediately harmed and could not be made whole by monetary damages. It is accordingly agreed that
the Parties (a) shall be entitled, in addition to any other remedy to which they may be entitled at law or in equity, to compel
specific performance of this Agreement; and (b) shall waive, in any action for specific performance, the defense of the adequacy
of a remedy at law.

 

10.17         Interpretation.
The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent and
no rule of strict construction shall be applied against any Party. Unless otherwise expressly specified in this Agreement: (a)
the words “hereof”, “hereby” and “hereunder,” and correlative words, refer
to this Agreement as a whole and not any particular provision; (b) the words “include”, “includes”
and “including”, and correlative words, are deemed to be followed by the phrase “without limitation”;
(c) the word “or” is not exclusive and is deemed to have the meaning “and/or”; (d) words
using the singular or plural number shall also include the plural or singular number, respectively; (e) the masculine, feminine
or neuter form of a word includes the other forms of such word and the singular form of a word includes the plural form of such
word; (f) references to a Person shall include the permitted successors and assigns thereof; (g) references made in this Agreement
to an Article, Section, Schedule or Exhibit mean an Article or Section of, or a Schedule or Exhibit to, this Agreement; and (h)
all consents and approvals are in the sole discretion of the Party requested to give such consent or approval, unless otherwise
expressly provided.

 

    	15

    	 

    

 

10.18         Mitigation.
Each Party shall take commercially reasonable efforts to mitigate its damages in the event of a breach of this Agreement by the
other Party.

 

10.19         Bankruptcy.
Notwithstanding any provision contained herein to the contrary, if Remedent is under any bankruptcy proceeding and the trustee
in bankruptcy of such party, or such party, as a debtor in possession, elects to reject this Agreement, GlamSmile may retain any
and all of the rights transferred or licensed to it hereunder, to the maximum extent permitted by law. The parties further agree
that GlamSmile shall be entitled to a complete duplicate of (or complete access to, as appropriate) any such intellectual property
and all embodiments of such intellectual property, and the same, if not already in its possession, shall be promptly delivered
to GlamSmile upon request

 

[remainder of page intentionally left
blank; signature page follows]

 

    	16

    	 

    

 

IN WITNESS WHEREOF,
Remedent and GlamSmile, by their respective authorized representatives set forth below, have signed this Agreement as of the Effective
Date.

 

	REMEDENT, INC.	 	REMEDENT, N.V.
	 “Remedent Nevada”	 	“Remedent Belgium”
	 	 	 	 	 
	By:	 	 	By:	 
	 	 	 	 	 
	Name:	Guy De Vreese	 	Name:	Guy De Vreese
	 	 	 	 	 
	Title:	Chief Executive Officer	 	Title:	Chief Executive Officer

 

	GLAMSMILE DENTAL TECHNOLOGY, LTD.

“GlamSmile”	 
	 	 
	By:	 	 
	 	 	 
	Name:	David Lok	 
	 	 	 
	Title:	Chief Executive Officer	 

 

Signature Page to Dental Tech Distribution Agreement-c

 

    	 

    	 

    

 

Schedule 1

 

Definitions

 

(a)          “Affiliate”
shall mean, with respect to an entity, any Person that, directly or indirectly, through one or more intermediaries, Controls, is
Controlled by, or is under common Control with, that entity.

 

(b)          “B2C
Market” shall mean the market for GlamSmile Veneer Product sold directly to consumers through retail locations.

 

(c)          
“Business Day” shall mean any day other than a Saturday, Sunday or any other day on which commercial banks in
New York are authorized or required by law to remain closed.

 

(d)          “Confidential
Information” of any Person shall mean all confidential or proprietary information of such Person, including financial
statements, customer and supplier lists, reports, marketing studies, and business plans and forecasts, whether written, oral, or
in electronic or other form and whether prepared by such Person, its Affiliates or its representatives.

 

(e)          “Den-Mat
Agreement” shall mean that certain Amended and Restated Distribution, License and Manufacturing Agreement, dated June
6, 2009, as amended from time to time thereafter, by and between Remedent Nevada, Remedent Belgium, and Den-Mat Holdings, LLC.

 

(f)          “Den-Mat”
shall mean Den-Mat Holdings, LLC.

 

(g)          “GlamSmile Veneer Products” shall mean all of Remedent’s veneer products (whether made in or out of Trays)
made of any material (e.g., hybrid porcelain and full porcelain) and any private label materials or tools used in the placement
of the veneers bearing the GlamSmile name or brand, and the GlamSmile Technology and Processes incorporated therein.

 

(h)          “GlamSmile
Technology and Processes” shall mean the Intellectual Property embedded in the GlamSmile Veneer Products licensed by
Remedent to GlamSmile pursuant to this Agreement, including process described in Annex B.

 

(i)          “Governmental
Authority” shall mean any: (a) federal, state, regional, county, city, municipal or local government, whether foreign
or domestic; (b) governmental or quasi-governmental authority of any nature, including any regulatory or administrative agency,
commission, department, board, bureau, court, tribunal, arbitrator, arbitral body, agency, branch, official entity or other administrative
or regulatory body obtaining authority from any of the foregoing, including courts and any supra-national organization, state,
county, city or other political subdivision; or (c) other Person exercising or entitled to exercise any administrative, executive,
judicial, legislative, police, regulatory or taxing authority or power of any nature.

 

Signature Page to Dental Tech Distribution Agreement-c

 

    	 

    	 

    

 

(j)          “Intellectual
Property” shall mean a patent, patent application, industrial design, invention, design, trade secret, idea, work, methodology,
technology, innovation, creation, concept, moral right, development drawing, research, analysis, know-how, experiment, copyright,
trademark, service mark, data, formula, method, procedure, process, system or technique and any registration, application, right
or other grant analogous thereto with respect to any of the foregoing.

 

(k)          “Knowledge
of GlamSmile” shall mean the actual knowledge of any of the executive officers of GlamSmile.

 

(l)          “Knowledge
of Remedent” shall mean the actual knowledge of any of the executive officers of either Remedent, Inc. or Remedent N.V.

 

(m)          “Law”
shall mean any treaty, code, statute, law, rule, regulation, convention, ordinance, Order, legally binding regulatory policy statement
or similar legally binding guidance, binding directive or decree of any kind of any Governmental Authority, as well as any common
law.

 

(n)          [Reserved]

 

(o)          “Order”
means any judgment, writ, decree, directive, decision, injunction, ruling, award or order (including any consent decree or cease
and desist order) of any kind.

 

(p)          “Party”
shall mean any of Remedent, Inc., Remedent N.V. or GlamSmile Dental Technology, Ltd., individually, and “Parties”
shall mean all of such Persons collectively. 

 

(q)          “Permit”
shall mean any permit, license, authorization, registration, franchise, approval, certificate, variance, waiver or other authorization,
approval, consent, clearance or similar right issued, granted or obtained by or from any Governmental Authority.

 

(r)          “Person”
shall mean any natural person, firm, partnership, association, corporation, company, trust, business trust, governmental entity
or other entity.

 

(s)          “Proceeding”
shall mean any action, suit, arbitration, mediation, litigation, hearing, investigation, inquiry or other proceeding of any kind.

 

(t)          “Product”
shall mean, the GlamsSmile Veneer Products intended to be sold in the B2C Market.

 

(u)          “Remedent-Hidens
Agreement” shall mean that certain Exclusive Distribution Agreement entered into by and between Remedent N.V. and Hidens
Co., Ltd. as of December 9, 2009.

 

(v)         “Territory”
shall mean the B2C Market in the countries listed in Annex A.

 

* * * *

 

    	2

    	 

    

 

Annex A

 

LIST OF COUNTRIES INCLUDED IN THE TERRITORY

 

Peoples Republic of China (including Hong Kong and Macau)

Republic of China (Taiwan)

 

    	 

    	 

    

 

Annex B

GlamSmile Technology and Processes

1.          Technology/procedure
for the construction of "veneer" placement tray and clinical methodology for simultaneous placement of multiple veneers

 

2.          Technology
used in the production and placement of GlamSmile veneer products, including but not limited to:

 

(a)          Digital
scanning by robotic scanner

 

(b)          Proprietary
digital design software for veneers (as well as design of reduction and occlusal trays)

 

(c)          3-D
printing of resin representations of digitally designed teeth and fully formulated resin reduction and occlusal trays for
insertion and use by dentist

 

(d)          Proprietary
investment material

 

(e)          Proprietary
porcelain

 

(f)          Proprietary glaze and decal technology

 

    	 

    	 

    

 

Schedule 7.1.3

 

Remedent Intellectual Property

Patents

 

Europe

International Publication Number: WO2006/021240 A1

International Publication Date: 03/02/2006

International Filing Date: 04/21/2005

International Application Number: PCT/EP2005/004285

 

USA

Dental Prostheses

Publication Number: US 2007/0292821 A1

Publication Date: 12/20/2007

Application Number: 11/661,218

§ 371(c)(1), (2), (4) Date: 02/26/2007

 

Trademarks

 

European Union Community Trademark

Trademark Name: GLAMSMILE

Filing Date: 06/04/2007

Date of Registration: 06/03/2008

Trademark Number: 005818414

Owner: Remedent N.V.

 

Benelux Trademark

Trademark Name: GLAMSMILE

Filing Date: 10/27/2006

Expiration Date: 10/27/2016

Registration Number: 0812055

Serial Number: 1114752

 

USA (Word Mark Published for Opposition)

Word Mark: GLAMSMILE

Filing Date: 08/16/2007

Published for Opposition: 07/01/2008

Serial Number: 77256546

Owner: (Applicant) Remedent N.V.

 

Republic of China (Taiwan)

Trademark Name: GLAMSMILE

Registration No.:
99046559

Owner: Remedent N.V.

 

    	 

    	 

    

 

Schedule 7.1.3 (continued)

 

Exceptions to Section 7.1.3:

 

The Intellectual Property Rights are the subject of that certain
Amended and Restated Distribution, License and Manufacturing Agreement, dated June 6, 2009, as amended from time to time thereafter,
by and between Remedent Nevada, Remedent Belgium, and Den-Mat Holdings, LLC. and that certain Exclusive Distribution Agreement,
dated December 2, 2009, by and between Remedent Belgium and Hidens Co., Ltd.FINAL

TERMINATION AND LICENSE AGREEMENT

 

THIS TERMINATION AND LICENSE
AGREEMENT (this “Agreement”) is entered into by and among Remedent, Inc., a Nevada corporation (“Remedent
Nevada”), Remedent N.V., a Belgian corporation (“Remedent Belgium”, and together with Remedent Nevada,
“Remedent”), and Den-Mat Holdings, LLC, a Delaware limited liability company (“Den-Mat”), as of
this 27 day of March 2012 (the “Effective Date”). Each of Remedent Nevada, Remedent Belgium and Den-Mat
may be individually referred to as a “Party” and collectively as the “Parties.”

 

WHEREAS, the Parties
entered into an Amended and Restated Distribution, License and Manufacturing Agreement, dated June 3, 2009, as amended time to
time (the “DLMA”);

 

WHEREAS, a Change of Control
of Den-Mat has occurred and Den-Mat and Remedent have extended the time period in which Den-Mat is obligated to provide the “Change
of Control Notice” set forth in Section 11.1 of the DLMA with respect to the aforementioned Change of Control to March
30, 2012:

 

WHEREAS, Den-Mat
and Remedent have engaged in discussions concerning the Exit Fee specified in Section 11.1, et
seq. of the DLMA and the Consulting Fees specified in Section 6.3 of the DLMA; and

 

WHEREAS, the Parties
now desire to terminate the DLMA and any Ancillary Agreements that were entered into by the Parties in connection with the DLMA
in exchange for a cash settlement payment and the non-exclusive license provided for herein. For purposes of this Agreement, “Ancillary
Agreements” shall mean any Non-Competition Agreements that may still be in force and effect between Den-Mat and Guy DeVreese
and Den-Mat and Evelyne Jacquemyns.

 

THEREFORE, Den-Mat and Remedent hereby agree
as follows:

 

1.0         Definitions.
For purposes of this Agreement, including, but not limited to, the license granted hereby, the following definitions will apply:

 

“Affiliate”
shall mean, with respect to an entity, any Person that, directly or indirectly, through one or more intermediaries, Controls, is
Controlled by, or is under common Control with, that entity.

 

“Control” (including
with correlative meanings, the terms “Controlling,” “Controlled by” and “under common Control with”)
shall mean the possession directly or indirectly of the power to direct or cause the direction of the management and policies of
an entity, whether through the ownership of voting securities, by trust, management agreement, contract or otherwise.

 

    	1

    	 

    

 

“Governmental Authority”
shall mean any (a) federal, state, regional, county, city, municipal or local government, whether foreign or domestic; or (b) governmental
or quasi- governmental authority of any nature, including any regulatory or administrative agency, commission, department, board,
bureau, court, tribunal, arbitrator, arbitral body, agency, branch, official entity or other administrative or regulatory body
obtaining authority from any of the foregoing.

 

“Intellectual Property”
shall mean a patent, patent application, industrial design, invention, design, trade secret, idea, work, methodology, technology,
innovation, creation, concept, moral right, development drawing, research, analysis, know-how, experiment, copyright, data, formula,
method, procedure, process, system or technique and any registration, application, license, right or other grant analogous thereto
with respect to any of the foregoing.

 

“Knowledge of Remedent”
shall mean the actual knowledge of any of the executive officers of either Remedent Nevada or Remedent Belgium.

 

“Person” shall mean
any natural person, firm partnership, association, corporation, company, trust, business trust, governmental entity or other juridical
person or entity.

 

“Products” shall
mean all of Den-Mat’s products and services that use the Intellectual Property licensed
to Den-Mat under the DLMA on the Effective Date of this Agreement.

 

“SensAble Commitment” shall mean Remedent’s
payment to SensAble Technologies, Inc. (“SensAble”) monies due from Remedent to SensAble under a certain OEM
Agreement between SensAble and Remedent dated June 30, 2008 to allow SensAble to release additional licenses to Den-Mat
and/or its Affiliates and distribution partners so that they may use the SensAble software as contemplated by the parties.

 

“Territory”
shall mean worldwide, except for the Excluded Territories attached hereto as Exhibit “A,”

 

“Third Person” shall mean any Person
who is not a Party to this Agreement.

 

2.0       Termination
of the Amended and Restated Distribution, License and Manufacturing Agreement. Subject to the terms and conditions of this
Agreement, as of the Effective Date, the Parties agree to terminate the DLMA and any and all Ancillary
Agreements.

 

3.0        
Settlement Payment. In consideration of the termination of the DLMA provided for in Section 2 of this Agreement, the non-exclusive
license set forth in Section 4 of this Agreement, and the SensAble Commitment, Den-Mat agrees
to pay to Remedent a lump sum cash payment of two hundred thousand dollars ($200,000.00) (the “Settlement Payment”),
which sum shall be in complete satisfaction of any outstanding cash payment that was or may be due to Remedent pursuant to the
DLMA. The Settlement Payment shall be paid by wire transfer in immediately available funds onto Remedent’s account; 

 

    	2

    	 

    

 

Bank coordinates as following
= Remedent NV, address = Zuiderlaan 1-3, bus 8; 9000 Gent − Belgium /Account number (IBAN) BE73 0014 3221 1060 − BIC
Code = GEBABEBB: Bank name = BNP Paribas Fortis; bank address = Warandeberg 3; 1000 Brussels − Belgium.

 

4.0         Grant of Non-exclusive
License of Intellectual Property. Subject to the terms and conditions of this Agreement, Remedent hereby grants to Den-Mat
a non-exclusive, irrevocable, perpetual, royalty free license to use within the Territory the Intellectual Property that was the
subject of the license to Den-Mat under the DLMA on the Effective Date and that is related to the Products, including any improvements
thereto, such as related patent applications (continuations, continuations-in-part, divisionals, re-issues, etc.). For clarification
purposes, this grant shall not include any rights to the trademark, service mark or domain names that include “Remedent”
or “Glamsmile.” Other than to an Affiliate of Den-Mat or to a manufacturer appointed by Den-Mat to manufacture the
Products to be sold by Den-Mat in the Territory, Den-Mat may not sublicense the Intellectual Property to any Third Party without
the prior written consent of Remedent. Other than in connection with a Change of Control of Den-Mat (including, but not limited
to, the sale of all, or substantially all, of Den-Mat’s assets, a transfer or other disposition of at least 50% of its equity
shares, membership interests, or stock whether by merger, reverse merger, consolidation, sale of assets or otherwise), this Agreement
(including the licenses granted herein) may not be transferred by Den-Mat to any Third Party without the prior written consent
of Remedent, which consent shall not be unreasonably withheld. For the avoidance of doubt, this Agreement (and the licenses granted
herein) may be freely assigned by Den-Mat just prior to and/or upon the occurrence of a Change of Control of Den-Mat. To the extent
that Den-Mat has made any filing with any Governmental Authority registering its rights as an “exclusive” distributor
or licensee of the Intellectual Property, Den-Mat agrees to cooperate in good faith with Remedent, at Remedent’s reasonable
expense, to make any additional filings with such Governmental Authority reflecting the nature and extent of the “non-exclusive”
license granted to Den-Mat by this Agreement.

 

5.0      Confidentiality
and Indemnification.

 

    5.1    
Confidential Information of Den-Mat. All Confidential Information with respect to Den-Mat and its Affiliates that was disclosed
to Remedent under the DLMA by Den-Mat, its Affiliates or representatives, whether in physical or intangible form, and all Confidential
Information regarding Den-Mat of which Remedent became aware of in connection with its performance of manufacturing and other
services on behalf of Den-Mat in connection with the DLMA, shall be held as confidential by Remedent. Such information shall at
all times remain the property of Den-Mat and Den-Mat shall own and retain all right, title and interest therein and thereto. Remedent
shall hold all Confidential Information in confidence, using the same degree of care to prevent unauthorized disclosure or access
that it uses with its own confidential information of similar type, and shall not disclose such Confidential Information to others,
allow others to access it, or use it in any way, commercially or otherwise, except in direct furtherance or enforcement of this
Agreement. Remedent may disclose Confidential Information to its employees and its attorneys, accountants and other confidential
advisors with a need to know such Confidential Information in connection with this Agreement or their representation of Remedent
generally; provided, however, that all such employees and advisors are bound by obligations to maintain the confidentiality
of the Confidential Information at least as protective as those set forth in this Agreement. Except as set forth herein, nothing
in this Agreement shall be construed as conveying any other right or license (implied or otherwise) to Remedent in such Den-Mat
Confidential Information.

 

    	3

    	 

    

 

5.1.1     Permitted Disclosure. If Remedent is compelled
to disclose all or any part of any Confidential Information by any Governmental Authority, it shall, to the extent practicable
and subject to applicable laws, first give prompt written notice of such request to Den-Mat to enable Den-Mat to seek a protective
order or take other appropriate measures to prevent or modify the disclosure, and shall, at Den-Mat’s expense, cooperate
in such efforts.

 

5.1.2     Exclusions. Confidential Information with
respect to Den-Mat and its Affiliates shall not include information if and to the extent Remedent can demonstrate such information:
(a) is or becomes known to the public other than by disclosure by Remedent in violation of this Agreement; (b) was known to Remedent
before disclosure hereunder, without a duty of confidentiality; (c) was independently developed by Remedent outside of this Agreement
and without reference to or use of any Confidential Information of Den-Mat; or (d) was rightfully obtained by Remedent from a
Third Party without a duty of confidentiality in favor of Den-Mat.

 

5.1.3     Injunctive Relief. Remedent acknowledges
and agrees that in the event of any breach or threatened breach of its obligations hereunder with respect to Confidential Information,
damages will not be an adequate remedy and Den-Mat shall be entitled to obtain injunctive relief, without having to post a bond
or other security.

 

5.2      Confidential Information
of Remedent. All Confidential Information with respect to Remedent and its Affiliates that was disclosed to Den-Mat under the
DLMA by Remedent, its Affiliates or representatives, whether in physical or tangible form, and all Confidential Information regarding
Remedent of which Den-Mat became aware of in connection with its performance of the DLMA shall be held as confidential by Den-Mat.
Such Confidential Information shall at all times remain the property of Remedent and Remedent shall own and retain all right, title
and interest therein and thereto, except for the interests granted to Den-Mat as part of the license contemplated by this Agreement.
Den-Mat shall hold all Confidential Information in confidence, using the same degree of care to prevent unauthorized disclosure
or access that it uses with its own confidential information of similar type, and shall not disclose such Confidential Information
to others, allow others to access it, or use it in any way, commercially or otherwise, except in direct furtherance of this Agreement.
Den-Mat may disclose the Remedent Confidential Information to its employees and its attorneys, accountants, financing sources
and other confidential advisors with a need to know such Confidential Information in connection with this Agreement or their representation
of Den-Mat generally; provided, however, that all such employees and advisors are bound by obligations to maintain
the confidentiality of such Confidential Information at least as protective as those set forth in this Agreement. Except as
set forth herein, nothing in this Agreement shall be construed as conveying any other right or license (implied or otherwise)
to Den-Mat in such Remedent Confidential Information.

 

5.2.1   Permitted
Disclosure. If Den-Mat is compelled to disclose all or any part of any Remedent Confidential Information by any Governmental
Authority, it shall, to the extent practicable and subject to applicable laws, first give prompt written notice of such request
to Remedent to enable Remedent to seek a protective order or take other appropriate measures to prevent or modify the disclosure,
and shall, at Remedent’s expense, cooperate in such efforts.

 

    	4

    	 

    

 

5.2.2   Exclusions. Confidential Information
with respect to Remedent and its Affiliates shall not include information if and to the extent Den-Mat can demonstrate such information:
(a) is or becomes known to the public other than by disclosure by Den-Mat in violation of this Agreement; (b) was known to Den-Mat
before disclosure hereunder, without a duty of confidentiality; (c) was independently developed by Den-Mat outside of this Agreement
and without reference to or use of any Confidential Information of Remedent; or (d) was rightfully obtained by Den-Mat from a
Third Party without a duty of confidentiality. Den-Mat may also use and disclose Confidential Information of Remedent to the extent
such information is otherwise permitted to be used or disclosed by Den-Mat pursuant to other provisions of this Agreement, including
to manufacturers who agree to maintain the confidentiality thereof on terms comparable to those set forth in this Section 5.

 

5.2.3   Injunctive Relief. Den-Mat acknowledges
and agrees that in the event of any breach or threatened breach of its obligations hereunder with respect to Confidential Information,
damages will not be an adequate remedy and Remedent shall be entitled to obtain injunctive relief, without having to post a bond
or other security.

 

5.3     Indemnification by
Den-Mat. Den-Mat shall defend, indemnify and hold harmless Remedent and its Affiliates and its and their respective officers,
directors, members, managers, employees, agents and representatives from and against any and all claims, judgments, damages, liabilities,
actions, demands, costs, expenses or losses, including reasonable attorneys’ fees and costs (collectively, “Liabilities”),
to the extent resulting from, arising out of, or in connection with, an act or omission of Den-Mat in connection with its sale
of the Products as defined herein, the performance of its obligations under this Agreement, or the breach of any representation,
warranty or covenant made by Den-Mat in this Agreement.

 

5.4    Indemnification
by Remedent. Remedent shall defend, indemnify and hold harmless Den-Mat and its Affiliates and its and their respective officers,
directors, members, managers, employees, agents and representatives from and against any and all Liabilities, to the extent resulting
from, arising out of, or in connection with, an act or omission by Remedent in connection with performance of its obligations under
this Agreement, or the breach of any representation, warranty or covenant made by Remedent in this Agreement.

 

5.5    IP Indemnity.
Remedent shall indemnify Den-Mat and its Affiliates and its and their respective officers, directors, members, managers, employees,
agents and representatives from and against any and all Liabilities, to the extent resulting from, arising out of, or in connection
with any infringement or alleged infringement of the Intellectual Property of Remedent licensed to Den-Mat hereunder that is related
to the Products, or any use or application thereof upon any Intellectual Property of any Person. If the manufacture, distribution,
marketing, licensing, sale or use of any Product or Intellectual Property, as contemplated by this Agreement, is enjoined as a
result of any Intellectual Property claim or judgment, then Remedent, in addition to its other obligations under this Agreement,
shall, at its option, (i) obtain for Den-Mat, at Remedent’s expense, any license required for Den-Mat to manufacture, market,

 distribute, license and sell the Products as contemplated
by this Agreement, or (ii) redesign the infringing item or items to be non-infringing, while maintaining the original function
thereof or (iii) replace the infringing item or items with an equivalent, non-infringing item approved by Den-Mat.

 

    	5

    	 

    

 

5.6    Indemnification
Procedures. A Party seeking indemnification under this Section 5 for itself or any of its Affiliates or any of
its or their respective officers, directors, members, managers, employees, agents and representatives (collectively in this capacity,
the “Indemnified Party”) shall promptly notify the Party from whom indemnification is sought (in this capacity,
the “Indemnitor”) of any Liability in respect of which such Indemnified Party intends to claim indemnification;
provided. however, that the failure to so notify the Indemnitor shall not affect the Indemnified Party’s rights to indemnification
hereunder except to the extent that the Indemnitor is materially prejudiced by such failure. With respect to any Liabilities that
relate to a Third Party claim, the Indemnified Party shall permit the Indemnitor to control the defense of any such Liabilities;
provided, however, if the Indemnified Party reasonably determines that the joint representation of the Indemnified
Party and the Indemnitor by a single counsel would result in a conflict of interest arising out of the joint representation by
counsel selected by the Indemnitor of the interests of the Indemnitor and the Indemnified Party, the Indemnitor shall be entitled
to engage separate counsel to represent the Indemnified Party (at the Indemnitor’s sole cost and expense) and, if the Indemnitor
fails to do so, the Indemnitor shall not be entitled to assume the Indemnified Party’s defense of such Liability. If the
Indemnitor assumes the defense of any Liability, the Indemnitor shall consult with the Indemnified Party for the purpose of allowing
the Indemnified Party to participate in such defense, but in such case the legal expenses of the Indemnified Party incurred as
a result of such participation shall be paid by the Indemnified Party. With respect to any Proceeding for which the Indemnitor
has assumed the defense of an Indemnified Party, the Indemnitor shall promptly inform the applicable Indemnified Party of all material
developments related thereto, including copying such Indemnified Party on all pleadings, filings and other correspondence relating
thereto. If the Indemnitor fails to assume and defend a Liability or if, after commencing or undertaking any such defense, the
Indemnitor fails to prosecute such Liability, the Indemnified Party shall have the right to undertake the defense or settlement
thereof. With respect to any Liabilities that relate to a Third Party claim, the Indemnified Party shall have the right to settle
such Liabilities, provided the Indemnified Party consents in writing to such settlement, which
consent shall not be unreasonably withheld.

 

6.0      Representations and Warranties of the Parties.

 

            6.1.    Representations and Warranties
of Den-Mat.

 

              6.1.1.     Authority. Den-Mat
has all the required power and authority to enter into this Agreement and to perform its obligations hereunder and to consummate
the transactions contemplated hereby. This Agreement, when executed, will be duly executed and delivered by Den-Mat, and shall
constitute a valid and binding obligation of Den-Mat enforceable against Den-Mat in accordance with its terms, except as such
enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereinafter
in effect, relating to or limiting creditors’ rights generally and (ii) general principles of equity (whether considered
in an action in equity or at law).

 

    	6

    	 

    

 

       6.1.2.     No Exit Fee Due
Upon Change of Control. Den-Mat represents and warrants that even though a Change of Control of Den-Mat has occurred under
Section 11.1 of the DLMA, the Exit Fee calculated under Section 11.2 of the DLMA is zero when using the EBITDA Multiple as defined
in Schedule 1(j)of the DLMA.

 

     6.2     Representations and Warranties of Remedent.

 

       6.2.1.    Authority.
Remedent Nevada and Remedent Belgium have all the required power and authority to enter into this Agreement and to perform their
obligations hereunder and to consummate the transactions contemplated hereby. This Agreement, when executed, will be duly executed
and delivered by Remedent Nevada and Remedent Belgium, and shall constitute a valid and binding obligation of Remedent Nevada and
Remedent Belgium, enforceable against them in accordance with its terms, except as such enforceability may be limited by (i) bankruptcy,
insolvency, reorganization, moratorium or other similar laws, now or hereinafter in effect, relating to or limiting creditors’
rights generally and (ii) general principles of equity (whether considered in an action in equity or at law).

 

       6.2.2.    No Exit Fee Due Upon
Change of Control. Remedent represents and warrants that even though a Change of Control of Den-Mat has occurred under Section
11.1 of the DLMA, the Exit Fee calculated under Section
11.2 of the DLMA is zero when using the EBITDA Multiple as defined in Schedule 1(j) of the DLMA and that Remedent has had a full
and fair opportunity to review, and will not challenge, such calculation.

 

6.2.2.    Intellectual
Property. (a) Remedent has all right, title and interest in and to the Intellectual Property related to the Products owned
by it and licensed to Den-Mat hereunder, free and clear of all liens or other encumbrances; (b) there is no claim or notice of
infringement of the Intellectual Property rights of any other Person pending or threatened in writing within the two (2) year
period preceding the date hereof, against Remedent relating to the operation of Remedent’s business; (c) each material item
of Intellectual Property related to the Products owned by Remedent and licensed to Den-Mat hereunder is valid, subsisting, in
full force and effect, has not been abandoned or passed into public domain, and all necessary registration, maintenance and renewal
documentation and fees in connection with such Intellectual Property of Remedent have been timely filed with the appropriate authorities
and paid in accordance with the provisions of the DLMA, as applicable; (d) to the Knowledge of Remedent, each material item of
Intellectual Property related to the Products licensed to and used by Remedent is valid, subsisting. in full force and effect,
has not been abandoned or passed into public domain, and all necessary registration, maintenance and renewal documentation and
fees in connection with such Intellectual Property used by Remedent have been timely filed with appropriate authorities and paid;
(e) to the Knowledge of Remedent, no Person is infringing or misappropriating the Intellectual Property of Remedent except for
such infringements or misappropriations that would not reasonably be likely to have, individually or in the aggregate, a material
adverse effect on Remedent, its business or its ability to fulfill its obligations under this Agreement; (f)
no present or former employee of Remedent has any proprietary, financial or other interest, direct or indirect, in any
material item of the Intellectual Property of Remedent related to the Products and licensed to Den-Mat hereunder; and (g) Remedent
has taken reasonable precautions to protect trade secrets constituting material Intellectual Property owned or used by Remedent
that are related to the Products and licensed to Den-Mat hereunder, including the execution of appropriate agreements. Use by
Remedent of the Intellectual Property owned or licensed by Remedent related to the Products and licensed to Den-Mat hereunder
does not infringe, misappropriate or violate any Intellectual Property rights of any Person.

 

    	7

    	 

    

 

7.0       Miscellaneous.

 

     7.1.    Entire Agreement.
This Agreement constitutes the full and entire understanding and agreement between the Parties with regard to the subject matters
hereof and thereof.

 

     7.2.   Governing Law. This Agreement shall be governed
by and construed in accordance with the laws of the State of California, without regard to the conflicts of law provisions.

 

     7.3.    Successors and Assigns. The terms
and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and permitted assigns
of the Parties.

 

     7.4.    Waivers and Amendments. Any term of this
Agreement may be amended and the observance or satisfaction of any condition to this Agreement may be waived (either generally
or in a particular instance and either retroactively or prospectively), only with the written consent of the Parties.

 

     7.5.    Counterparts; Facsimile. This Agreement
may be executed in any number of counterparts, each of which shall be an original, but all of which together shall be deemed to
constitute one instrument. Executed copies of this Agreement may be exchanged via facsimile or other simultaneous electronic means,
and such signatures shall be deemed to be original signatures.

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, Remedent Nevada, Remedent Belgium, and Den-Mat, by their respective authorized representatives set forth
below, have signed this Agreement as of the Effective Date.

 

	
        REMEDENT, INC.

        “Remedent Nevada”
	 	
        REMEDENT, N.V. 

        “Remedent Belgium”

	 	 	 
	 	 	 	 	 
	By:	/s/ Guy De Vreese	 	By:	/s/ Guy De Vreese
	Name:	Guy De Vreese	 	Name:	Guy De Vreese
	Title:	CEO	 	Title:	CEO

 

 

	
        DEN-MAT HOLDINGS, LLC

        “Den-Mat”
	 	”
	 	 	 
	 	 	 	 	 
	By:	 	 	 	 
	Name:	Todd J. Tiberi	 	 	 
	Title:	Chief Administrative Officer	 	 	 

  

    	9

    	 

    

 

FINAL

EXHIBIT “A”

EXCLUDED
TERRITORIES

 

Abkhazia

Akrotiri & Dhekella

Afghanistan

Armenia

Ascension

Azerbaijan

Bahrain

Bangladesh

Bhutan

British Indian Ocean Territory

Brunei

Burma

Cambodia

China

Christmas Island

Cocos (Keeling) Islands

Cyprus, Republic of

East Timor

Gaza Strip

Georgia

Golan Heights

Hong Kong

Indonesia

Iran

Iraq

Israel

Jordan

Kazakhstan

Keeling Islands

Kurdistan

Kuwait

Kyrgyzstan

Laos

Lebanon

Macau

Malaysia

Maldives

Mongolia

Myanmar

 

    	1

    	 

    
  

EXHIBIT “A” CONT.

EXCLUDED TERRITORIES

 

Nagorno-Karabakh

Nepal

North Korea

Northern/Turkish Cyprus

Oman

Pakistan

Palestine

Philippines

Qatar

Saudi Arabia

South Ossetia

Sri Lanka

Syria

Taiwan (Republic of China)

Tajikistan

Thailand

Turkmenistan

Uzbekistan

Vietnam

West Bank

West Papua

Yemen

 

    	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]